Sherpa, YuanBio et al Continue to Support Hep B Treatment
01 Sep 2026
US$ 20.00
Sherpa Healthcare Partners, YuanBio Venture Capital, and Qiming Venture Partners have made follow-on investments in ......
Related Publications
Subscribers’ Weekly...
JM Financial Asset Management Ltd has raised 7 bn rupees (US$73.7 m) for the first close of its JM Financial India ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.